Stocks and InvestingStocks and Investing
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022

David Risinger Maintained (AMGN) at Hold with Increased Target to $282 on, Dec 22nd, 2022


Published on 2024-10-28 00:41:39 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of SVB Leerink, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $256 to $282 on, Dec 22nd, 2022.

David has made no other calls on AMGN in the last 4 months.



There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022


These are the ratings of the 5 analyists that currently disagree with David


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $299 on, Tuesday, December 13th, 2022
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
  • Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
  • Carter Gould of "Barclays" Downgraded from Hold to Sell and Held Target at $234 on, Monday, October 31st, 2022